Metformin Hydrochloride 500.00 mg + Voglibose 0.30 mg + Gliclazide 40.00 mg

LOYZIDE 40.03 is a fixed dose combination tablet that contains Voglibose (0.30mg), Metformin Hydrochloride (500.00mg), and Gliclazide (40.00mg). These ingredients work together to manage blood sugar levels in patients with type 2 diabetes. Voglibose helps reduce postprandial blood glucose levels by inhibiting certain enzymes that break down carbohydrates. Metformin Hydrochloride improves insulin sensitivity and decreases glucose production in the liver, while Gliclazide stimulates insulin release from the pancreas. This combination therapy helps control blood sugar levels and reduces the risk of complications associated with diabetes. LOYZIDE 40.03 should be used as prescribed by a healthcare professional in conjunction with a healthy diet and exercise.

Take LOYZIDE 40.03 orally with food to minimize gastrointestinal side effects. The dosage and frequency will be determined by your doctor based on your individual condition. It is important to follow their instructions and do not exceed the prescribed dose.

Allopathic

The contents and information provided here are solely intended to provide a general overview of the products and medicines and must be used for informational purposes only. This may not cover everything about particular health conditions, lab tests, medicines, all possible side effects, drug interactions, warnings, alerts, etc. The information contained herein should not be used as a substitute for the advice of a qualified physician. For all queries or doubts related to your medical condition, we highly recommend that you consult your registered medical practitioner.